Key facts
- This page summarizes Thomas von Koch's Form 4 filing for DiaMedica Therapeutics Inc. (DMAC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Jul 2025, 17:49.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
These shares are owned directly by TomEnterprise Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares.